Terminated PHASE2 INTERVENTIONAL 3-arm NCT00307827

Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects With Intravenous Steroid-refractory Ulcerative Colitis

Sponsor: Abbott

Conditions Ulcerative Colitis

Interventions Visilizumab

Updated 7 times since 2017 Last updated: Apr 26, 2012 Started: Apr 30, 2006 Primary completion: Nov 30, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study Canceled

Other terminated trials from Abbott

See all terminations from Abbott

Other Ulcerative Colitis trials with similar outcome

Browse all Ulcerative Colitis trials

This PHASE2 trial investigates Ulcerative Colitis and is currently terminated or withdrawn. Abbott leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott

Data source: Abbott

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Badalona - Barcelona, Spain , Bologna, Italy , Chapel Hill, United States , Cleveland, United States , Hamilton, Canada , Majadahonda (Madrid), Spain , Manhasset, United States , Moscow, Russia , Nizhny Novgorod, Russia , Osijek, Croatia and 5 more locations